STOCK TITAN

Accelerant Holdings SEC Filings

ARX NYSE

Welcome to our dedicated page for Accelerant Holdings SEC filings (Ticker: ARX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Accelerant Holdings (NYSE: ARX) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Accelerant is incorporated in the Cayman Islands and its Class A common shares are registered under Section 12(b) of the Exchange Act, trading on the New York Stock Exchange under the symbol ARX.

As a public company and emerging growth company, Accelerant files current reports on Form 8-K to announce material events, including the release of quarterly earnings results and the availability of earnings presentations. These 8-K filings often include or reference press releases that detail Exchange Written Premium, total revenues, net income or loss, Adjusted EBITDA, Adjusted Net Income and other key performance metrics for the specialty insurance risk exchange platform.

Investors can also use this page to locate periodic reports such as Forms 10-Q and 10-K once filed, which are expected to provide more extensive information on Accelerant’s financial statements, risk factors, business description and management’s discussion and analysis. The company has indicated that it files its Form 10-Q within the timelines applicable to a non-accelerated filer and emerging growth company.

In addition, the filings page is a resource for tracking capital markets and corporate structure disclosures, including the registration statement on Form S-1 that supported Accelerant’s initial public offering and the listing of its Class A common shares on the NYSE. Over time, users can review how Accelerant reports on its fee-based revenue model, the composition of Exchange Written Premium, the use of non-GAAP financial measures and items such as profit interest distribution expenses, share-based compensation and foreign currency effects.

Stock Titan enhances these documents with AI-powered summaries that highlight the main points of lengthy filings, helping readers quickly understand the significance of each report while still allowing full access to the underlying SEC documents for detailed review.

Rhea-AI Summary

Accelerant Holdings (ARX) – Form 4 insider filing dated 29 Jul 2025 shows Director Karen Sue Meriwether received 9,210 Class A common share RSUs on 25 Jul 2025. Each RSU represents one share and was granted at a stated price of $0, indicating a routine equity-based compensation award rather than an open-market purchase. After the grant, Meriwether’s direct beneficial ownership stands at 9,210 shares; no prior shareholdings are disclosed in this filing, suggesting these RSUs constitute her entire reported stake. The filing reports no sales, option exercises or derivative positions. While the grant modestly aligns the director’s interests with shareholders, the single, small transaction (<1 % of outstanding shares) carries limited market impact and does not alter control dynamics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Accelerant Holdings (ARX) – Form 4 filed 07/29/2025: Director Paul Christopher Little was granted 9,210 Class A Restricted Stock Units (RSUs) on 07/25/2025 (Transaction Code “A”). Each RSU represents the contingent right to receive one Class A common share, effectively increasing the director’s direct beneficial ownership to 9,210 shares.

No cash consideration was paid (price reported as $0), indicating the shares were awarded as equity compensation rather than purchased on the open market. The filing contains no derivative transactions and lists no prior holdings, implying these RSUs constitute Mr. Little’s entire reported stake. Because RSUs typically vest over time, the award aligns the director’s future compensation with shareholder value while causing only minimal immediate dilution to existing holders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Accelerant Holdings (ARX) – Form 4 insider filing: Co-Founder, Director and Head of Distribution Christopher Lee-Smith reported IPO-related equity conversions dated 25 Jul 2025.

  • 17,509,884 Class A Common Shares were received under transaction code C, arising from the exchange of limited-partnership interests in Accelerant Holdings LP. Lee-Smith now directly owns the same number of Class A shares.
  • Table II shows the mechanics: 107,086,944 LP interests converted into the above Class A shares; all derivative LP units now show 0 remaining.
  • 62,132 Redeemable Preference Shares were redeemed by the issuer at $31.55 each (code D). Post-redemption, the preference stake is 0.

No open-market purchases or sales occurred; the filing simply documents the restructuring of Lee-Smith’s pre-IPO holdings into the public share class. The insider retains a sizeable equity position and remains both a director and executive officer. No other financial metrics or guidance were disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Accelerant Holdings (ARX) – Form 4 insider activity. Director & General Counsel Nancy Hasley reported several transactions dated 07/25/2025 that coincided with the company’s initial public offering.

  • Conversions (Code C): 1,368,640 Class A shares received for limited-partnership interests; 512,531 shares received indirectly via an irrevocable trust; 17,025 shares issued from automatic conversion of preference shares.
  • Open-market purchase (Code P): Hasley’s spouse bought 500 Class A shares at $21 through the IPO’s directed-share program.
  • Redemption (Code D): 22,190 redeemable preference shares were redeemed by the issuer at $31.55 per share.

Post-transactions Hasley owns 1,385,665 Class A shares directly and 512,531 shares indirectly, for total beneficial exposure of roughly 1.9 million shares. The filing reflects mandatory IPO-related conversions rather than sales, suggesting the insider maintains a substantial equity stake aligned with public shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Accelerant Holdings (ARX) – Insider Ownership Update

COO Matthew David Sternberg filed an amended Form 3 reporting one derivative position: an employee stock option covering 884,464 Class A shares at an exercise price of $19.31. Twenty-five percent vested after one year; the remaining 75 % vest in 6.25 % quarterly tranches over the next three years. The option expires 09/01/2033. The amendment corrects the 07/23/2025 filing, which overstated the share count by one share and understated the exercise price by $0.01. No non-derivative holdings were disclosed, and the filing does not alter share count, dilution, or cash flow for existing investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Accelerant Holdings (ARX) – Form 3/A: Director Paul Christopher Little discloses ownership of a single stock-option grant covering 165,831 Class A shares with a $19.31 exercise price. Twenty-five percent vests after one year; the remaining 75% vests in 6.25% quarterly installments over the next three years, contingent on continued service. This amendment corrects the prior Form 3 filed 23 Jul 2025, reducing the option by one share and increasing the exercise price by $0.01. No other equity positions or material changes are reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Accelerant Holdings (ARX) Form 4 filing: Co-founder & CEO Jeffrey L. Radke was granted 8,279,552 stock options on 23 Jul 2025 at an exercise price of $21 per Class A common share. The options expire on 23 Jul 2035.

Vesting schedule: 25 % vests on 23 Jul 2026; the remaining 75 % vests in 6.25 % quarterly tranches through 23 Jul 2029, subject to continuous service. Following the grant, Radke beneficially owns the full 8.28 M derivative securities directly.

Take-aways for investors: the award is sizable and represents future dilution if exercised, but it strengthens management-shareholder alignment and serves as a long-term retention incentive for the CEO.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
insider
Rhea-AI Summary

On 07/23/2025, Co-Founder & Chief Underwriting Officer Francis James O’Neill received a stock option covering 882,611 Class A common shares of Accelerant Holdings (ARX) at an exercise price of $21, as disclosed in a Form 4 filed 07/25/2025.

Vesting terms tie the award to long-term service: 25% vests on 07/23/2026 and the remaining 75% vests in 6.25% quarterly installments through 07/23/2029. The award is coded “A,” indicating a grant with no cash payment or share sale. O’Neill now beneficially owns 882,611 derivative securities, all held directly.

The grant increases potential dilution if exercised but aligns executive compensation with future share-price performance by requiring four years of continued service before full vesting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
insider

FAQ

What is the current stock price of Accelerant Holdings (ARX)?

The current stock price of Accelerant Holdings (ARX) is $10.71 as of February 26, 2026.

What is the market cap of Accelerant Holdings (ARX)?

The market cap of Accelerant Holdings (ARX) is approximately 2.3B.

ARX Rankings

ARX Stock Data

2.27B
58.03M
Insurance Brokers
Insurance Agents, Brokers & Service
Link
Cayman Islands
GRAND CAYMAN

ARX RSS Feed